Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome

Autores
Russo, Matias Irineo; Márquez, María Antonela; Andrada, Lidia Estefania; Gauffin Cano, María Paola; Medina, Roxana Beatriz
Año de publicación
2022
Idioma
inglés
Tipo de recurso
documento de conferencia
Estado
versión publicada
Descripción
Metabolic syndrome (MS) is one of the most relevant health problems in the world due to increased consumption of high-fat diets and the consequent obesity. MS is a cluster of cardio-metabolic risk factors and comorbidities conveying high risk of both cardiovascular disease and type 2 diabetes. Comorbidities associated with MS include proinflammatory state, prothrombotic state, nonalcoholic fatty liver disease. Lactobacillus johnsonii CRL1231 (Lj) is a strain with feruloyl esterase activity which increases the release of ferulic acid (FA) in the intestine and improves the biomarkers of MS. When the AF esterified in bran fibers is released, it can exert its lipid-lowering effect. The objective of this work was to evaluate the effect of oral administration of Lj on accumulation of abdominal and hepatic fat, and inflammatory state of mice with MS induced by a high-fat diet supplemented with wheat bran (HFD+WB). Male six-week-old Swiss albino mice (n = 24) were fed for 14 weeks; they were divided into 3 groups: Control group: mice received water and normal diet; MS group: mice received water and HFD+WB; MS+Lj group: mice received suspension of Lj (dose: 108 CFU / day / mouse) and HFD+WB. The adiposity index (AI) was calculated: AI = [Fat weight / Body weight] x 100. Histopathological analysis of liver and epididymal adipose tissue (evaluation of adipocyte area) was performed. Plasma levels of AST and ALT transaminases were measured by enzymatic methods and leptin levels by immunoassay. Cytokine levels (TNF-α, IFN-γ, IL-6 and IL-10) were determined by flow cytometry. The AI was 2 times higher in MS group compared to Control group, and decreased 30% in MS+Lj group compared to MS group. Abundance of large adipocytes (4000-8000 μm2) was 9% in Control group, 57% in MS group, and it was reduced to 20% in MS+Lj group. Plasma leptin levels were 7 times higher in MS group than in Control group, and 2 times lower in MS+Lj group with respect to MS group. The levels of pro-inflammatory cytokines (TNF-α, IFN-γ, IL-6) increased in MS group compared to Control group, and decreased in MS+Lj group. The levels of anti-inflammatory IL-10 were reduced 3 times in MS group compared to Control group, but an increase of 2 times was evidenced in the MS+Lj group. Liver histology revealed steatosis in the MS group and showed a reduction in fatty infiltration in hepatocytes of the MS+Lj group. Increased levels of ALT and AST are often associated with liver damage resulting from unhealthy habits, such as a high-fat diet. Results showed that ALT and AST levels increased 2 times in MS group with respect to Control group, while MS+Lj group did not show significant differences with the Control group. According to the results obtained in this work, oral administration of Lj reduces AI, prevents hypertrophy of adipose tissue, decreases hyperleptinemia, and improves the inflammatory profile and steatosis in mice with MS fed HFD+WB.
Fil: Russo, Matias Irineo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Márquez, María Antonela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Andrada, Lidia Estefania. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Gauffin Cano, María Paola. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Medina, Roxana Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology
Ciudad Autónoma de Buenos Aires
Argentina
Sociedad Argentina de Investigación Bioquímica y Biología Molecular
Sociedad Argentina de Microbiología General
Materia
BACTERIAS LACTICAS
PROBIOTICOS
SINDROME METABOLICO
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/263344

id CONICETDig_8f6a1f5d97dd26164d86836b72ee8c1b
oai_identifier_str oai:ri.conicet.gov.ar:11336/263344
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndromeRusso, Matias IrineoMárquez, María AntonelaAndrada, Lidia EstefaniaGauffin Cano, María PaolaMedina, Roxana BeatrizBACTERIAS LACTICASPROBIOTICOSSINDROME METABOLICOhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Metabolic syndrome (MS) is one of the most relevant health problems in the world due to increased consumption of high-fat diets and the consequent obesity. MS is a cluster of cardio-metabolic risk factors and comorbidities conveying high risk of both cardiovascular disease and type 2 diabetes. Comorbidities associated with MS include proinflammatory state, prothrombotic state, nonalcoholic fatty liver disease. Lactobacillus johnsonii CRL1231 (Lj) is a strain with feruloyl esterase activity which increases the release of ferulic acid (FA) in the intestine and improves the biomarkers of MS. When the AF esterified in bran fibers is released, it can exert its lipid-lowering effect. The objective of this work was to evaluate the effect of oral administration of Lj on accumulation of abdominal and hepatic fat, and inflammatory state of mice with MS induced by a high-fat diet supplemented with wheat bran (HFD+WB). Male six-week-old Swiss albino mice (n = 24) were fed for 14 weeks; they were divided into 3 groups: Control group: mice received water and normal diet; MS group: mice received water and HFD+WB; MS+Lj group: mice received suspension of Lj (dose: 108 CFU / day / mouse) and HFD+WB. The adiposity index (AI) was calculated: AI = [Fat weight / Body weight] x 100. Histopathological analysis of liver and epididymal adipose tissue (evaluation of adipocyte area) was performed. Plasma levels of AST and ALT transaminases were measured by enzymatic methods and leptin levels by immunoassay. Cytokine levels (TNF-α, IFN-γ, IL-6 and IL-10) were determined by flow cytometry. The AI was 2 times higher in MS group compared to Control group, and decreased 30% in MS+Lj group compared to MS group. Abundance of large adipocytes (4000-8000 μm2) was 9% in Control group, 57% in MS group, and it was reduced to 20% in MS+Lj group. Plasma leptin levels were 7 times higher in MS group than in Control group, and 2 times lower in MS+Lj group with respect to MS group. The levels of pro-inflammatory cytokines (TNF-α, IFN-γ, IL-6) increased in MS group compared to Control group, and decreased in MS+Lj group. The levels of anti-inflammatory IL-10 were reduced 3 times in MS group compared to Control group, but an increase of 2 times was evidenced in the MS+Lj group. Liver histology revealed steatosis in the MS group and showed a reduction in fatty infiltration in hepatocytes of the MS+Lj group. Increased levels of ALT and AST are often associated with liver damage resulting from unhealthy habits, such as a high-fat diet. Results showed that ALT and AST levels increased 2 times in MS group with respect to Control group, while MS+Lj group did not show significant differences with the Control group. According to the results obtained in this work, oral administration of Lj reduces AI, prevents hypertrophy of adipose tissue, decreases hyperleptinemia, and improves the inflammatory profile and steatosis in mice with MS fed HFD+WB.Fil: Russo, Matias Irineo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaFil: Márquez, María Antonela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaFil: Andrada, Lidia Estefania. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaFil: Gauffin Cano, María Paola. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaFil: Medina, Roxana Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaLVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General MicrobiologyCiudad Autónoma de Buenos AiresArgentinaSociedad Argentina de Investigación Bioquímica y Biología MolecularSociedad Argentina de Microbiología GeneralTech Science Press2022info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectReuniónJournalhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/263344Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome; LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology; Ciudad Autónoma de Buenos Aires; Argentina; 2021; 103-1040327-95451667-5746CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.techscience.com/biocell/v46nSuppl.1Internacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:09:56Zoai:ri.conicet.gov.ar:11336/263344instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:09:57.175CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome
title Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome
spellingShingle Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome
Russo, Matias Irineo
BACTERIAS LACTICAS
PROBIOTICOS
SINDROME METABOLICO
title_short Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome
title_full Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome
title_fullStr Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome
title_full_unstemmed Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome
title_sort Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome
dc.creator.none.fl_str_mv Russo, Matias Irineo
Márquez, María Antonela
Andrada, Lidia Estefania
Gauffin Cano, María Paola
Medina, Roxana Beatriz
author Russo, Matias Irineo
author_facet Russo, Matias Irineo
Márquez, María Antonela
Andrada, Lidia Estefania
Gauffin Cano, María Paola
Medina, Roxana Beatriz
author_role author
author2 Márquez, María Antonela
Andrada, Lidia Estefania
Gauffin Cano, María Paola
Medina, Roxana Beatriz
author2_role author
author
author
author
dc.subject.none.fl_str_mv BACTERIAS LACTICAS
PROBIOTICOS
SINDROME METABOLICO
topic BACTERIAS LACTICAS
PROBIOTICOS
SINDROME METABOLICO
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Metabolic syndrome (MS) is one of the most relevant health problems in the world due to increased consumption of high-fat diets and the consequent obesity. MS is a cluster of cardio-metabolic risk factors and comorbidities conveying high risk of both cardiovascular disease and type 2 diabetes. Comorbidities associated with MS include proinflammatory state, prothrombotic state, nonalcoholic fatty liver disease. Lactobacillus johnsonii CRL1231 (Lj) is a strain with feruloyl esterase activity which increases the release of ferulic acid (FA) in the intestine and improves the biomarkers of MS. When the AF esterified in bran fibers is released, it can exert its lipid-lowering effect. The objective of this work was to evaluate the effect of oral administration of Lj on accumulation of abdominal and hepatic fat, and inflammatory state of mice with MS induced by a high-fat diet supplemented with wheat bran (HFD+WB). Male six-week-old Swiss albino mice (n = 24) were fed for 14 weeks; they were divided into 3 groups: Control group: mice received water and normal diet; MS group: mice received water and HFD+WB; MS+Lj group: mice received suspension of Lj (dose: 108 CFU / day / mouse) and HFD+WB. The adiposity index (AI) was calculated: AI = [Fat weight / Body weight] x 100. Histopathological analysis of liver and epididymal adipose tissue (evaluation of adipocyte area) was performed. Plasma levels of AST and ALT transaminases were measured by enzymatic methods and leptin levels by immunoassay. Cytokine levels (TNF-α, IFN-γ, IL-6 and IL-10) were determined by flow cytometry. The AI was 2 times higher in MS group compared to Control group, and decreased 30% in MS+Lj group compared to MS group. Abundance of large adipocytes (4000-8000 μm2) was 9% in Control group, 57% in MS group, and it was reduced to 20% in MS+Lj group. Plasma leptin levels were 7 times higher in MS group than in Control group, and 2 times lower in MS+Lj group with respect to MS group. The levels of pro-inflammatory cytokines (TNF-α, IFN-γ, IL-6) increased in MS group compared to Control group, and decreased in MS+Lj group. The levels of anti-inflammatory IL-10 were reduced 3 times in MS group compared to Control group, but an increase of 2 times was evidenced in the MS+Lj group. Liver histology revealed steatosis in the MS group and showed a reduction in fatty infiltration in hepatocytes of the MS+Lj group. Increased levels of ALT and AST are often associated with liver damage resulting from unhealthy habits, such as a high-fat diet. Results showed that ALT and AST levels increased 2 times in MS group with respect to Control group, while MS+Lj group did not show significant differences with the Control group. According to the results obtained in this work, oral administration of Lj reduces AI, prevents hypertrophy of adipose tissue, decreases hyperleptinemia, and improves the inflammatory profile and steatosis in mice with MS fed HFD+WB.
Fil: Russo, Matias Irineo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Márquez, María Antonela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Andrada, Lidia Estefania. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Gauffin Cano, María Paola. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Medina, Roxana Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology
Ciudad Autónoma de Buenos Aires
Argentina
Sociedad Argentina de Investigación Bioquímica y Biología Molecular
Sociedad Argentina de Microbiología General
description Metabolic syndrome (MS) is one of the most relevant health problems in the world due to increased consumption of high-fat diets and the consequent obesity. MS is a cluster of cardio-metabolic risk factors and comorbidities conveying high risk of both cardiovascular disease and type 2 diabetes. Comorbidities associated with MS include proinflammatory state, prothrombotic state, nonalcoholic fatty liver disease. Lactobacillus johnsonii CRL1231 (Lj) is a strain with feruloyl esterase activity which increases the release of ferulic acid (FA) in the intestine and improves the biomarkers of MS. When the AF esterified in bran fibers is released, it can exert its lipid-lowering effect. The objective of this work was to evaluate the effect of oral administration of Lj on accumulation of abdominal and hepatic fat, and inflammatory state of mice with MS induced by a high-fat diet supplemented with wheat bran (HFD+WB). Male six-week-old Swiss albino mice (n = 24) were fed for 14 weeks; they were divided into 3 groups: Control group: mice received water and normal diet; MS group: mice received water and HFD+WB; MS+Lj group: mice received suspension of Lj (dose: 108 CFU / day / mouse) and HFD+WB. The adiposity index (AI) was calculated: AI = [Fat weight / Body weight] x 100. Histopathological analysis of liver and epididymal adipose tissue (evaluation of adipocyte area) was performed. Plasma levels of AST and ALT transaminases were measured by enzymatic methods and leptin levels by immunoassay. Cytokine levels (TNF-α, IFN-γ, IL-6 and IL-10) were determined by flow cytometry. The AI was 2 times higher in MS group compared to Control group, and decreased 30% in MS+Lj group compared to MS group. Abundance of large adipocytes (4000-8000 μm2) was 9% in Control group, 57% in MS group, and it was reduced to 20% in MS+Lj group. Plasma leptin levels were 7 times higher in MS group than in Control group, and 2 times lower in MS+Lj group with respect to MS group. The levels of pro-inflammatory cytokines (TNF-α, IFN-γ, IL-6) increased in MS group compared to Control group, and decreased in MS+Lj group. The levels of anti-inflammatory IL-10 were reduced 3 times in MS group compared to Control group, but an increase of 2 times was evidenced in the MS+Lj group. Liver histology revealed steatosis in the MS group and showed a reduction in fatty infiltration in hepatocytes of the MS+Lj group. Increased levels of ALT and AST are often associated with liver damage resulting from unhealthy habits, such as a high-fat diet. Results showed that ALT and AST levels increased 2 times in MS group with respect to Control group, while MS+Lj group did not show significant differences with the Control group. According to the results obtained in this work, oral administration of Lj reduces AI, prevents hypertrophy of adipose tissue, decreases hyperleptinemia, and improves the inflammatory profile and steatosis in mice with MS fed HFD+WB.
publishDate 2022
dc.date.none.fl_str_mv 2022
dc.type.none.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/conferenceObject
Reunión
Journal
http://purl.org/coar/resource_type/c_5794
info:ar-repo/semantics/documentoDeConferencia
status_str publishedVersion
format conferenceObject
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/263344
Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome; LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology; Ciudad Autónoma de Buenos Aires; Argentina; 2021; 103-104
0327-9545
1667-5746
CONICET Digital
CONICET
url http://hdl.handle.net/11336/263344
identifier_str_mv Effect of oral administration of Lactobacillus johnsonii CRL1231 on adiposity and inflammatory status of mice with metabolic syndrome; LVII Annual Meeting of the Argentine Society for Biochemistry and Molecular Biology Research; XVI Annual Meeting of the Argentinean Society for General Microbiology; Ciudad Autónoma de Buenos Aires; Argentina; 2021; 103-104
0327-9545
1667-5746
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.techscience.com/biocell/v46nSuppl.1
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.coverage.none.fl_str_mv Internacional
dc.publisher.none.fl_str_mv Tech Science Press
publisher.none.fl_str_mv Tech Science Press
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613983509676032
score 13.070432